The American Journal of Chinese Medicine · 2015 · 27 citations · 17 references
MedicineOncologyPharmacologyCancer PharmacologyCarcinogenesisMolecular OncologyLung CancerMalignant NeoplasmsMitotic InhibitorsOncogenic Signaling PathwaysAnticancer ActivityCancer Cell Proliferation InhibitionCell Cycle InhibitionFlow Cytometric AnalysisMedicinal HerbsMitosis ArrestNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer Treatment
Lung cancer is the leading cause of cancer-related death worldwide. Non-small cell lung cancer (NSCLC) accounts for 80% of lung cancer cases and the reported overall 5-year survival rate is less than 5%. Natural medicines have attracted much attention due to their lower toxicity and fewer side effects. Trichosanthes kirilowii Maxim (TKM) fruits are commonly used in cancer treatment in combination with other Chinese medicinal herbs. However, little is known about their biological functions and mechanisms in NSCLC cells. In this study, we investigated the efficacy of TKM fruits in NSCLC cells using cell proliferation, invasion, migration, and anchorage independent assays and a Xenograft NSCLC tumor model, and explored the possible biological mechanism by flow cytometric analysis, cDNA microarray and real-time PCR. Results showed that TKM fruits significantly suppressed NSCLC cell proliferation, migration, invasion, tumorigenicity and tumor growth, and significantly extended the survival time of NSCLC-bearing mice. Flow cytometric analysis showed that TKM fruits significantly induced G2-M arrest, necrosis and apoptosis in NSCLC cells. cDNA microarray analysis revealed that TKM fruits regulated the differential expression of 544 genes, and the differential expression of selected genes was also confirmed. Gene ontology (GO) analysis showed that 18 of first 20 biological processes were involved in cell cycle and mitosis. These results indicate that TKM fruits have certain inhibitory effect on NSCLC cells through cell-cycle and mitosis arrest, and suggest that TKM fruits may be an important resource for developing new antitumor drugs, and a potent natural product for treating patients with NSCLC.
17
Cyclin is a component of maturation-promoting factor from Xenopus
Jean Gautier, Jeremy Minshull, Manfred J. Lohka et al. · Cell · 1990 · 672 citations
The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells
Karl Riabowol, Giulio Draetta, Leonardo Brizuela et al. · Cell · 1989 · 440 citations
An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
Michael J. Moore, Qingqing Wang, Caleb J. Kennedy et al. · Cell · 2010 · 318 citations · Full text
Development of Cell-Cycle Inhibitors for Cancer Therapy
Mark A. Dickson, Gary K. Schwartz · Current Oncology · 2009 · 244 citations · Full text
Medicine, Oncology, Pharmacology +17